Zoe Fox

Publikationer pr. år

Fingeraftryk

Dyk ned i forskningsemnerne, hvor Zoe Fox er aktive. Disse emneetiketter kommer fra denne persons arbejder. Sammen danner de et unikt fingerprint.

1 Lignende profiler

4 Tidsskriftartikel
1 Poster

A prospective study of nutritional status in immunoglobulin light chain amyloidosis
Sattianayagam, P. T., Lane, T., Fox, Z., Petrie, A., Gibbs, S. D. J., Pinney, J. H., Risom, S. S., Rowczenio, D. M., Wechalekar, A. D., Lachmann, H. J., Gilbertson, J. A., Hawkins, P. N. & Gillmore, J. D., jan. 2013, I: Haematologica. 98, 1, s. 136-40 5 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
26 Citationer (Scopus)
Diminished susceptibility to didanosine due to 184I/Vand thymidine analog mutations in isolates without major IAS-USA didanosine-specific and cross-resistant mutations
Kjær, J., Cozzi-Lepri, A., Fox, Z. & Lundgren, J. D., 2007.
Publikation: Konferencebidrag › Poster › Forskning
Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2.
Fox, Z., Antunes, F., Davey, R., Gazzard, B., Klimas, N., Labriola, A., Losso, M., Neaton, J., Phillips, A., Ruxrungtham, K., Staszewski, S., Weiss, L. & Lundgren, J. D., 2007, I: HIV Medicine. 8, 2, s. 112-23
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
7 Citationer (Scopus)
Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe. A EuroSIDA study, 1994-2000.
Yust, I., Fox, Z., Burke, M., Johnson, A., Turner, D., Mocroft, A., Katlama, C., Ledergerber, B., Reiss, P. & Kirk, O., 2004, I: European Journal of Clinical Microbiology & Infectious Diseases.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.
Bidragets oversatte titel: Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.Dragsted, U. B., Gerstoft, J., Pedersen, C., Peters, B., Duran, A., Obel, N., Castagna, A., Cahn, P., Clumeck, N., Bruun, J. N., Benetucci, J., Hill, A., Cassetti, I., Vernazza, P., Youle, M., Fox, Z. & Lundgren, J. D., 2003, I: Journal of Infectious Diseases. 188, 5, s. 635-642 8 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

119 Citationer (Scopus)

Zoe Fox

Fingeraftryk

Publikation

A prospective study of nutritional status in immunoglobulin light chain amyloidosis

Diminished susceptibility to didanosine due to 184I/Vand thymidine analog mutations in isolates without major IAS-USA didanosine-specific and cross-resistant mutations

Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2.

Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe. A EuroSIDA study, 1994-2000.

Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.